Why Is Biohaven Stock Falling On Thursday?

finance.yahoo.com/news/why-biohaven-stock-falling-thursday-172243621.html

In This Article:
Biohaven Ltd. (NYSE:BHVN) shares plunged on Thursday after the Food and Drug Administration (FDA) unexpectedly delayed the review date for its rare-disease drug troriluzole.
The Division of Neurology 1 within FDA’s Office of Neuroscience informed Biohaven that they are…

This story appeared on finance.yahoo.com, 2025-05-15 17:22:43.
The Entire Business World on a Single Page. Free to Use →